Gerresheimer (ETR:GXI) received a €65.00 ($80.25) price target from analysts at Kepler Capital Markets in a report released on Friday. The brokerage presently has a “sell” rating on the stock. Kepler Capital Markets’ price objective would suggest a potential downside of 2.55% from the stock’s previous close.
Several other analysts have also recently commented on GXI. Berenberg Bank set a €78.00 ($96.30) target price on Gerresheimer and gave the company a “buy” rating in a research report on Friday, March 9th. Deutsche Bank set a €66.00 ($81.48) target price on Gerresheimer and gave the company a “neutral” rating in a research report on Monday, January 22nd. JPMorgan Chase & Co. set a €87.70 ($108.27) target price on Gerresheimer and gave the company a “buy” rating in a research report on Thursday, January 4th. equinet set a €75.00 ($92.59) target price on Gerresheimer and gave the company a “neutral” rating in a research report on Friday, January 19th. Finally, Hauck & Aufhaeuser set a €55.00 ($67.90) target price on Gerresheimer and gave the company a “sell” rating in a research report on Thursday, January 18th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of €69.85 ($86.24).
Shares of Gerresheimer (ETR:GXI) opened at €66.70 ($82.35) on Friday. Gerresheimer has a 1 year low of €59.97 ($74.04) and a 1 year high of €78.25 ($96.60). The company has a market capitalization of $2,100.00 and a P/E ratio of 20.78.
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.